Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amicus Therapeutics Inc

AM6
Current price
9.45 EUR 0 EUR (0.00%)
Last closed 9.7 EUR
Company
ISIN US03152W1099
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 3 105 667 207 EUR
Yield for 12 month -2.58 %
1Y
3Y
5Y
10Y
15Y
AM6
21.11.2021 - 28.11.2021

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey. Address: 47 Hulfish Street, Princeton, NJ, United States, 08542

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.03 EUR

P/E ratio

Dividend Yield

Current Year

+378 734 055 EUR

Last Year

+312 232 066 EUR

Current Quarter

+134 209 345 EUR

Last Quarter

+120 128 066 EUR

Current Year

+343 335 495 EUR

Last Year

+275 626 242 EUR

Current Quarter

+121 616 046 EUR

Last Quarter

+109 448 562 EUR

Key Figures AM6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 23 337 468 EUR
Operating Margin TTM 17.53 %
PE Ratio
Return On Assets TTM 1.16 %
PEG Ratio
Return On Equity TTM -67.09 %
Wall Street Target Price 16.03 EUR
Revenue TTM 498 983 576 EUR
Book Value 0.61 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 36.7 %
Dividend Yield
Gross Profit TTM 293 761 615 EUR
Earnings per share -0.32 EUR
Diluted Eps TTM -0.32 EUR
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -21.21 %

Dividend Analytics AM6

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AM6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation AM6

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 36.2319
Enterprise Value Revenue 7.0468
Price Sales TTM 6.224
Enterprise Value EBITDA -33.5489
Price Book MRQ 18.037

Financials AM6

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AM6

For 52 weeks

8.29 EUR 13.34 EUR
50 Day MA 10.16 EUR
Shares Short Prior Month
200 Day MA 10.22 EUR
Short Ratio
Shares Short
Short Percent